Personalized Microbiome-Based Approaches to Early Onset Colorectal Cancer Prevention, Diagnosis and Management - SP2: Unravel the tumor microbiome and mycobiome and its implication for oncogenic signaling (PerMiCCion)
Basic data for this project
Type of project: Participation in federally funded joint project
Duration at the University of Münster: 01/04/2022 - 31/03/2026 | 1st Funding period
Description
Keywords: Darmkrebs
Website of the project: http://www.permiccion.de/
Funding identifier: 01KD2101F
Funder / funding scheme:
- Federal Ministry of Research, Technology and Space (BMFTR)
Project management at the University of Münster
| Bleckmann, Annalen | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) Westdeutsches Tumorzentrum (WTZ) Netzwerkpartner Münster |
Applicants from the University of Münster
| Bleckmann, Annalen | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) Westdeutsches Tumorzentrum (WTZ) Netzwerkpartner Münster |
Research associates from the University of Münster
| Menck, Kerstin | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
Project partners outside the University of Münster
- University of BonnGermany
- Jena University Hospital (UKJ)Germany
- Heidelberg University Hospital (UKH)Germany
- University Medical Center Freiburg (UKF)Germany
- University Medical Center Göttingen (UMG)Germany
- Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (Leibniz-HKI)Germany
- Josephs-Hospital Warendorf (JHW)Germany
- Bio-mENorway
- DNANutriCoachSpain
- Genetic Analysis AS (GA)Norway
- SNIPR BiomeDenmark
Coordinating organisations outside the University of Münster
- Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (Leibniz-HKI)Germany